SKU: D072  / 
    CAS Number: 1195765-45-7


    $122.54 - $228.35
    Dabrafenib is a selective inhibitor of BRAF, a proto-oncogene. It is primarily used for the treatment of late-stage melanoma.
    Mechanism of ActionDabrafenib is a reversible and potent adenosine triphosphate-competitive inhibitor that selectively inhibits the BRAFV600E kinase.
    Molecular FormulaC23H20F3N5O2S2
    ReferencesMurali, R., M., & Long, G. (2012). Dabrafenib and its potential for the treatment of metastatic melanoma. DDDT Drug Design, Development and Therapy, 391. doi:10.2147/dddt.s38998